What is the GHS hazard classification for Galaxolide?
Galaxolide (CAS 1222-05-5) is classified under EU CLP Annex VI as Aquatic Acute 1; Aquatic Chronic 1 with signal word Warning. Hazard statements: H400; H410. Source: EU CLP Annex VI (ECHA).
Also known as: 1,3,4,6,7,8-hexahidro-4,6,6,7,8,8-hexametilindeno[5,6-c]pirano, 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8- HEXAMETHYL CYCLOPENTA-γ-2-BENZOPYRAN, 1,3,4,6,7,8-HEXAHYDRO-4,6,6,7,8,8-HEXAMETHYL CYCLOPENTA-[g]-2-BENZOPYRAN, 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclo-penta[g]-2-benzo pyrane, 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran (+11 more)
CAS 1222-05-5
Galaxolide (CAS 1222-05-5) is a chemical substance with GHS signal word Warning; key hazard signal: H400; H410. Key regulatory status: REACH registered, 19 regulatory/inventory lists, cosmetic ingredient cross-reference; source data from ECHA CLP, EPA ToxValDB, EPA CPDat, AICIS, ECHA REACH, EPA TRI.
CAS, identifiers, formula, and alternate names for the matched substance record.
EU harmonized hazard classification, hazard statements, pictograms, and signal word.
| Hazard Class | H-Statements | Pictograms | Signal |
|---|---|---|---|
| Aquatic Acute 1; Aquatic Chronic 1 | H400; H410 | GHS09 | Warning |
Industrial and product-use categories associated with this substance.
Inventory, screening, and regulatory list matches from public chemical databases.
| List | Keyword | Source |
|---|---|---|
| IFRA Transparency | IFRA | IFRA |
| Europe | European Chemicals Agency | European Chemicals Agency (ECHA) |
| inert_ingredient; non_food_use; Pesticides | EPA | CPCat |
| Other direct contact consumer goods | Environmental Health Perspectives | Published Articles |
| detected; MN Chemical Screening; surface_water | USGS | State of Minnesota |
| detected; MN Chemical Screening; surface_water | National Parks Service | State of Minnesota |
| detected; MN Chemical Screening; surface_water | NPS & EPA | State of Minnesota |
| detected; wastewater | USGS | United States Geological Survey (USGS) |
| detected; drinking_water; MN Chemical Screening | EPA & USGS | State of Minnesota |
| detected; drinking_water; MN Chemical Screening | EPA & USGS | State of Minnesota |
| detected; drinking_water; MN Chemical Screening | EPA & USGS | State of Minnesota |
| detected; drinking_water; MN Chemical Screening | EPA & USGS | State of Minnesota |
| Cleaning products and household care - air freshener; Europe | Danish Environmental Protection Agency | Danish EPA |
| detected; MN Chemical Screening; wastewater | Minnesota Pollution Control Agency | State of Minnesota |
| detected; MN Chemical Screening; surface_water | Minnesota Pollution Control Agency | State of Minnesota |
| detected; drinking_water; MN Chemical Screening | USGS | State of Minnesota |
| detected; drinking_water; MN Chemical Screening | USGS | State of Minnesota |
| detected; MN Chemical Screening; surface_water | Minnesota Pollution Control Agency | State of Minnesota |
| detected; ground_water; MN Chemical Screening | Minnesota Pollution Control Agency | State of Minnesota |
Toxicology endpoints rendered from public NOAEL study rows.
| Value | Unit | Endpoint | Route | Species | Source |
|---|---|---|---|---|---|
| 50 | mg/kg | - | - | - | UnifiedCodex:SCCNFP:beta.noael_studies |
| =13.5 | mg/m3 | DNEL systemic | inhalation | Human | ToxValDB_GESTIS_DNEL |
| 14170060AT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 14170060AT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 14170060AT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| 14170060AT | UNII | FDA UNII substance identifier | - | - | openFDA substances |
| - | % | Incidence of positive responses | Dermal | Human | NTP_ICE_skin_sensitization |
| 9720 | ug/cm2 | Induction dose per skin area | Dermal | Human | NTP_ICE_skin_sensitization |
| >4640 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| >5000 | mg/kg bw | LD50 | oral | Rat | NTP_ICE_acute_oral |
| =34 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =38 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =150 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =300 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =300 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_HPVIS |
| =500 | mg/kg bw/day | LOAEL | oral | Rat | ToxValDB_EPA_TSCA_8e |
| =20 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =30 | mg/kg bw/day | NOAEL | oral | Rabbit | ToxValDB_ECHA_IUCLID |
| =50 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =50 | mg/kg | NOAEL | dermal | human | SCCNFP_vision_codex |
| =50 | mg/kg | NOAEL | dermal | human | SCCNFP_vision_codex |
| =50 | mg/kg | NOAEL | dermal | human | SCCNFP_vision_codex |
| =50 | mg/kg | NOAEL | dermal | human | SCCNFP_vision_codex |
| >=100 | mg/kg bw/day | NOAEL | oral | Rabbit | ToxValDB_ECHA_IUCLID |
| <121 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =150 | mg/kg bw/day | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| =300 | mg/kg bw/day | NOAEL | oral | Rabbit | ToxValDB_ECHA_IUCLID |
| >=1650 | ppm | NOAEL | oral | Rat | ToxValDB_ECHA_IUCLID |
| 3 | unitless | Relative reliability score | Dermal | Human | NTP_ICE_skin_sensitization |
| =50 | mg/kg | dermal absorption | dermal | human | UnifiedCodex:SCCNFP:beta.noael_studies |
| =50 | mg/kg | dermal absorption | dermal | human | UnifiedCodex:SCCNFP:beta.noael_studies |
| =50 | mg/kg | dermal absorption | dermal | human | UnifiedCodex:SCCNFP:beta.noael_studies |
Showing 32 of 32 studies
Registration status from the ECHA REACH registered substances database.
| Status | Name | EC Number | Link |
|---|---|---|---|
| Registered | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran | 214-946-9 | ECHA overview → |
TRI hazard and reporting flags for the matched chemical.
| Chemical | Category | Flags |
|---|---|---|
| 1,3,4,6,7,8-Hexahydro-4,6,6,7,8,8-hexamethylcyclopenta[g]-2-benzopyran (HHCB) | - | - |
Australian industrial chemicals inventory status and applicable conditions.
Same-CAS cosmetic ingredient record for cross-vertical context.
Same-CAS pharmaceutical records from drug and bioactivity sources.
Galaxolide (CAS 1222-05-5) is classified under EU CLP Annex VI as Aquatic Acute 1; Aquatic Chronic 1 with signal word Warning. Hazard statements: H400; H410. Source: EU CLP Annex VI (ECHA).
Galaxolide has 32 NOAEL studies in the database. The lowest reported value is 13.5 mg/m3 via inhalation in Human. Source: ToxValDB_GESTIS_DNEL.
Galaxolide appears on 10 regulatory/inventory lists including IFRA Transparency, Europe, inert_ingredient; non_food_use; Pesticides, and 7 more. Source: EPA CPDat.
Yes, Galaxolide is also indexed as a cosmetic ingredient under the name Galaxolide. View the full cosmetic safety profile on the ingredient page for detailed safety data, SCCS opinions, and regulatory status.
Safety data is sourced from ECHA CLP Annex VI, EPA ToxValDB, EPA CPDat, AICIS (Australian Industrial Chemicals Introduction Scheme), EPA DSSTox, ECHA REACH, EPA Toxics Release Inventory, CosIng / Ingredients DB, ChEMBL / DailyMed. All data traces to primary regulatory sources and is updated from official government databases.
Galaxolide also appears in cosmetics, pharmaceutical databases.